Skip to main content

Table 4 Factors associated with the intermediate-high/high early mortality risk groups, binary logistic regression

From: The relation between thrombus burden and early mortality risk in inpatients diagnosed with COVID-19-related acute pulmonary embolism: a retrospective cohort study

 

Univariate analysis

Multivariate analysis

 

cOR

95% CI

p-value

aOR

95% CI

p-value

Total simplified Mastora score

1.06

1.02–1.10

0.003

1.06

1.02–1.11

0.008

Male gender

1.12

0.35–3.61

0.85

2.04

0.42–10.00

0.38

Age (years)

1.02

0.98–1.05

0.31

1.02

0.97–1.06

0.51

Presence of comorbidity

2.36

0.61–9.05

0.21

3.91

0.65–23.26

0.14

Patients with DVT

2.44

0.76–7.86

0.13

2.36

0.55–10.25

0.25

Diagnosed with SARS-CoV-2 PCR

0.39

0.13–1.19

0.098

0.93

0.23–3.83

0.92

Favipiravir treatment

0.18

0.05–0.65

0.009

0.13

0.02–0.93

0.041

HCQ treatment

2.47

0.80–7.63

0.12

0.87

0.16–4.62

0.87

  1. cOR: crude odds ratio, aOR: adjusted odds ratio, CI: Confidence interval,
  2. DVT: Deep vein thrombosis, SARS-CoV-2: Severe acute respiratory syndrome-Coronavirus-2
  3. PCR: Polymerase chain reaction, HCQ: Hydroxychloroquine
  4. The analysis was completed with 87 patients. Hosmer-Lemeshow p-value = 0.19, Nagelkerke R2 = 0.348